Two Florida-based real estate developers are planning to break ground on three Florida medical office buildings in the fall, according to a June 28 report from the South Florida Business Journal.
OptumRx, Optum’s pharmacy benefit management company, has agreed to pay $20 million to settle allegations it improperly filled certain opioid prescriptions, violating the Controlled Substances Act.
The majority of prior authorizations for ophthalmology patients seeking anti-vascular endothelial growth factor medications have been linked to delays in care, according to a June 27 study published in JAMA Ophthalmology.
Optum, parent company of ASC chain SCA Health, has called off its plan to acquire financially troubled Steward Health Care’s 1,700-physician group, The Boston Globe reported June 27.